Search filters

MediaShop acquires BtoC AG and the UBTC-mail order business

The German/Austrian retail group MediaShop has acquired the Swiss online retailer BtoC AG and the mail order business of UBTC Switzerland AG. The transaction was structured as a share and asset deal and marks a further cornerstone...

myneva Group收购SWING

位于汉堡的私募股权公司BID Equity旗下的一家投资组合公司,myneva Group收购了总部位于德国弗莱堡和瑞士苏尔西的软件供应商SWING。myneva Group是一家领先的社会领域软件供应商,通过收购SWING提升了其针对门诊和综合护理供应商的产品范围。 VISCHER在这次跨境交易中担任BID Equity的瑞士法律顾问。VISCHER团队由Jürg Luginbühl(合伙人,公司/并购)、Sebastian P....

Polyneuron将A轮融资扩大到3650万瑞士法郎

Polyneuron Pharmaceuticals AG将其A轮融资扩大1400万瑞士法郎,使总额达到3650万瑞士法郎。Polyneuron是一临床阶段研发机构,其研发用于治疗自身免疫性疾病的新型抗原特异性聚合物。在主要投资人Sofinnova Partners和New Enterprise Associates之外,HBM Healthcare Investments追加成为投资人。VISCHER由Matthias Staehelin...

AFINUM acquires Threema

AFINUM has acquired Threema GmbH, Freienbach (CH), the Swiss developer and provider of the leading European secure messenger solution for professional and personal communication. As part of this transaction, the three founders...

Polyphor grants Fosun Pharma license for balixafortide in China

Polyphor AG (SIX: POLN) and Shanghai Fosun Pharmaceutical (Group) Co. Ltd ("Fosun Pharma", stock code: 600196.SH; 02196.HK), through its Swiss affiliate Fosun Pharmaceutical AG entered into an exclusive licensing agreement for...

T3 Pharma closes 25M CHF financing round

T3 Pharmaceuticals AG (“T3 Pharma”), a Swiss biotech advancing immuno-oncology with its bacteria-based protein delivery platform, closed its third financing round, raising over 25M CHF. The financing was co-led by existing...

Polyphor enters into CHF 19.3 million equity-linked financing arrangement

Polyphor AG has entered into an equity-linked financing arrangement with the French company IRIS to raise a gross amount of up to CHF 19.3 million over a period of two years. Under the financing instrument, IRIS will receive...

Versameb在种子轮融资中筹集600万瑞士法郎

Versameb AG已交割一项600万瑞士法郎的种子轮融资。Versameb致力于探索和开发下一代基于RNA的药物。为此,Versameb利用其公司专有的VERSagile技术平台开发针对皮肤病学、肿瘤学和肌学领域的免疫应答或再生能力调节的分子。

VISCHER AG公司法团队的Matthias Staehelin,Moritz Jäggy和Dania Salvisberg-Schneider为Versameb提供建议。

Bregal收购了GUS Group的多数股权

Bregal Unternehmerkapital收购了位于科隆的GUS Group的多数股权。GUS Group是一家为加工业领域中型企业提供企业软件的领军供应商之一。本次对GUS Group的投资标志着Bregal在企业软件领域的第五次合作。

VISCHER是Bregal在本次跨境交易中的瑞士顾问。本次团队由Jürg Luginbühl(合伙人,公司/并购)领导,成员包括Christian Gutzwiller(律师,公司/并购),Elias...

Polares Medical交割一项4000万美元的临床试验研究融资

位于洛桑的Polares Medical SA是一家临床阶段医疗技术公司,致力于开发一种独特的经导管二尖瓣半置换系统,以治疗二尖瓣反流(MR)患者。该公司交割了一项由Longitude Capital经度资本(门罗帕克)牵头的价值4000万美元融资,Decheng Capital德诚资本(门罗帕克),Endeavour Vision(日内瓦),IDO Investments(马斯喀特),Earlybird Venture...

You are currently offline. Some pages or content may fail to load.